| 000 | 01646 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513111640.0 | ||
| 264 | 0 | _c19970227 | |
| 008 | 199702s 0 0 eng d | ||
| 022 | _a0026-895X | ||
| 024 | 7 |
_a10.1124/mol.51.1.69 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMa, X | |
| 245 | 0 | 0 |
_aDiscordant hepatic expression of the cell division control enzyme p34cdc2 kinase, proliferating cell nuclear antigen, p53 tumor suppressor protein, and p21Waf1 cyclin-dependent kinase inhibitory protein after WY14,643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid) dosing to rats. _h[electronic resource] |
| 260 |
_bMolecular pharmacology _cJan 1997 |
||
| 300 |
_a69-78 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCDC2 Protein Kinase _xanalysis |
| 650 | 0 | 4 |
_aCarcinogens _xtoxicity |
| 650 | 0 | 4 | _aChromatography, Gel |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p21 |
| 650 | 0 | 4 |
_aCyclins _xanalysis |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aLiver _xchemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPolychlorinated Dibenzodioxins _xtoxicity |
| 650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xanalysis |
| 650 | 0 | 4 |
_aPyrimidines _xtoxicity |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xanalysis |
| 700 | 1 | _aStoffregen, D A | |
| 700 | 1 | _aWheelock, G D | |
| 700 | 1 | _aRininger, J A | |
| 700 | 1 | _aBabish, J G | |
| 773 | 0 |
_tMolecular pharmacology _gvol. 51 _gno. 1 _gp. 69-78 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/mol.51.1.69 _zAvailable from publisher's website |
| 999 |
_c9006885 _d9006885 |
||